France debates medical devices as strategic sovereignty investment

French government faces budgetary choices on medical devices, weighing cost containment vs. strategic investment for health sovereignty and reindustrialization. The opinion piece argues for treating the sector as strategic, but no policy decision has been made. This signals a potential shift in French industrial and health policy priorities.